IBDEI16D ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20747,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,20748,0)
 ;;=782.3^^112^1284^10
 ;;^UTILITY(U,$J,358.3,20748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20748,1,3,0)
 ;;=3^782.3
 ;;^UTILITY(U,$J,358.3,20748,1,4,0)
 ;;=4^Edema
 ;;^UTILITY(U,$J,358.3,20748,2)
 ;;=^38340
 ;;^UTILITY(U,$J,358.3,20749,0)
 ;;=278.00^^112^1284^19
 ;;^UTILITY(U,$J,358.3,20749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20749,1,3,0)
 ;;=3^278.00
 ;;^UTILITY(U,$J,358.3,20749,1,4,0)
 ;;=4^Obesity
 ;;^UTILITY(U,$J,358.3,20749,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,20750,0)
 ;;=280.9^^112^1284^14
 ;;^UTILITY(U,$J,358.3,20750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20750,1,3,0)
 ;;=3^280.9
 ;;^UTILITY(U,$J,358.3,20750,1,4,0)
 ;;=4^Iron Defic Anemia
 ;;^UTILITY(U,$J,358.3,20750,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,20751,0)
 ;;=780.79^^112^1284^17
 ;;^UTILITY(U,$J,358.3,20751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20751,1,3,0)
 ;;=3^780.79
 ;;^UTILITY(U,$J,358.3,20751,1,4,0)
 ;;=4^Malaise And Fatigue
 ;;^UTILITY(U,$J,358.3,20751,2)
 ;;=^73344
 ;;^UTILITY(U,$J,358.3,20752,0)
 ;;=783.21^^112^1284^21
 ;;^UTILITY(U,$J,358.3,20752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20752,1,3,0)
 ;;=3^783.21
 ;;^UTILITY(U,$J,358.3,20752,1,4,0)
 ;;=4^Weight Loss, Abnormal
 ;;^UTILITY(U,$J,358.3,20752,2)
 ;;=^322005
 ;;^UTILITY(U,$J,358.3,20753,0)
 ;;=250.90^^112^1284^9
 ;;^UTILITY(U,$J,358.3,20753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20753,1,3,0)
 ;;=3^250.90
 ;;^UTILITY(U,$J,358.3,20753,1,4,0)
 ;;=4^Dm Type II, With Comp
 ;;^UTILITY(U,$J,358.3,20753,2)
 ;;=^33626
 ;;^UTILITY(U,$J,358.3,20754,0)
 ;;=250.91^^112^1284^8
 ;;^UTILITY(U,$J,358.3,20754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20754,1,3,0)
 ;;=3^250.91
 ;;^UTILITY(U,$J,358.3,20754,1,4,0)
 ;;=4^Dm Type I, With Comp
 ;;^UTILITY(U,$J,358.3,20754,2)
 ;;=^267850
 ;;^UTILITY(U,$J,358.3,20755,0)
 ;;=278.01^^112^1284^18
 ;;^UTILITY(U,$J,358.3,20755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20755,1,3,0)
 ;;=3^278.01
 ;;^UTILITY(U,$J,358.3,20755,1,4,0)
 ;;=4^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,20755,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,20756,0)
 ;;=278.02^^112^1284^20
 ;;^UTILITY(U,$J,358.3,20756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20756,1,3,0)
 ;;=3^278.02
 ;;^UTILITY(U,$J,358.3,20756,1,4,0)
 ;;=4^Overweight
 ;;^UTILITY(U,$J,358.3,20756,2)
 ;;=^332745
 ;;^UTILITY(U,$J,358.3,20757,0)
 ;;=250.02^^112^1284^6
 ;;^UTILITY(U,$J,358.3,20757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20757,1,3,0)
 ;;=3^250.02
 ;;^UTILITY(U,$J,358.3,20757,1,4,0)
 ;;=4^DM Type II,Uncontrolled
 ;;^UTILITY(U,$J,358.3,20757,2)
 ;;=^331781
 ;;^UTILITY(U,$J,358.3,20758,0)
 ;;=250.03^^112^1284^4
 ;;^UTILITY(U,$J,358.3,20758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20758,1,3,0)
 ;;=3^250.03
 ;;^UTILITY(U,$J,358.3,20758,1,4,0)
 ;;=4^DM Type I, Uncontrolled
 ;;^UTILITY(U,$J,358.3,20758,2)
 ;;=^331782
 ;;^UTILITY(U,$J,358.3,20759,0)
 ;;=V58.67^^112^1284^16
 ;;^UTILITY(U,$J,358.3,20759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20759,1,3,0)
 ;;=3^V58.67
 ;;^UTILITY(U,$J,358.3,20759,1,4,0)
 ;;=4^Long-Term Use of Insulin
 ;;^UTILITY(U,$J,358.3,20759,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,20760,0)
 ;;=780.60^^112^1284^11
 ;;^UTILITY(U,$J,358.3,20760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20760,1,3,0)
 ;;=3^780.60
 ;;^UTILITY(U,$J,358.3,20760,1,4,0)
 ;;=4^Fever NOS
 ;;^UTILITY(U,$J,358.3,20760,2)
 ;;=^336764
 ;;^UTILITY(U,$J,358.3,20761,0)
 ;;=286.59^^112^1284^2
 ;;^UTILITY(U,$J,358.3,20761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,20761,1,3,0)
 ;;=3^286.59
 ;;^UTILITY(U,$J,358.3,20761,1,4,0)
 ;;=4^Anticoag Disorder
 ;;
 ;;$END ROU IBDEI16D
